Hiroshi Hojo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroshi Hojo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Masafumi Abe
First Department of Pathology, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima, 960-1295, Japan
3 shared publicationsMichiko Sato
First Department of Pathology, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima, 960-1295, Japan
2 shared publicationsNaoya Nakamura
First Department of Pathology, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima, 960-1295, Japan
2 shared publicationsYoshikazu Sasaki
First Department of Pathology, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima, 960-1295, Japan
2 shared publicationsAsumi Shirakawa
First Department of Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan
1 shared publication- Hiroyuki Suzuki
Department of Chest Surgery, Fukushima Medical University , Fukushima
1 shared publication
Latest Publications
- Open Access
- 12 February 2019
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 14 (1) , 1-5
Wine cup stoma anastomosis after extended sleeve lobectomy for central-type squamous cell lung cancer
Extended sleeve lobectomy is rarely applied to pulmonary surgery for primary lung cancer to avoid a pneumonectomy. As there is a size discrepancy between main bronchus and peripheral bronchus, ingenuity to improve anastomosis is required in the bronchoplasty. We report herein a case in which successful reconstruction of extended sleeve lobectomy with bronchial wall flap. We report on a 64-year-old man suffering from hemoptysis, cough, mild fever and dyspnea. His computed tomography (CT) scan showed solid tumor of 40 mm in diameter in left lower bronchus, which obstructed the lower bronchus and caused obstructive pneumonia of left lower lobe and expanded to second carina and pulmonary artery. His bronchoscopy showed that tumor was exposed in the bronchial lumen and infiltrated to left main bronchus and upper bronchus even though the scope could pass through the exposed tumor of upper bronchus. Transbronchial lung biopsy showed squamous cell carcinoma. He had undergone left sleeve lingular segmentectomy and left lower lobectomy. Reconstruction was performed with bronchial wall flap. Pathological findings revealed pT3N0M0 stage IIB according to UICC 8th edition. Postoperative bronchoscopic findings showed no troubles at the anastomotic site. He has been well for eighteen months without recurrence after surgery. We experienced a successful case who was reconstructed with bronchial wall flap (wine cup stoma) after extended sleeve lobectomy. This technique might be also useful for other types of extended sleeve lobectomy and lung transplantation to adjust caliber changes of bronchi.
- 12 February 2019
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 14 (1) , 1-5
Open AccessWine cup stoma anastomosis after extended sleeve lobectomy for central-type squamous cell lung cancer
Extended sleeve lobectomy is rarely applied to pulmonary surgery for primary lung cancer to avoid a pneumonectomy. As there is a size discrepancy between main bronchus and peripheral bronchus, ingenuity to improve anastomosis is required in the bronchoplasty. We report herein a case in which successful reconstruction of extended sleeve lobectomy with bronchial wall flap. We report on a 64-year-old man suffering from hemoptysis, cough, mild fever and dyspnea. His computed tomography (CT) scan showed solid tumor of 40 mm in diameter in left lower bronchus, which obstructed the lower bronchus and caused obstructive pneumonia of left lower lobe and expanded to second carina and pulmonary artery. His bronchoscopy showed that tumor was exposed in the bronchial lumen and infiltrated to left main bronchus and upper bronchus even though the scope could pass through the exposed tumor of upper bronchus. Transbronchial lung biopsy showed squamous cell carcinoma. He had undergone left sleeve lingular segmentectomy and left lower lobectomy. Reconstruction was performed with bronchial wall flap. Pathological findings revealed pT3N0M0 stage IIB according to UICC 8th edition. Postoperative bronchoscopic findings showed no troubles at the anastomotic site. He has been well for eighteen months without recurrence after surgery. We experienced a successful case who was reconstructed with bronchial wall flap (wine cup stoma) after extended sleeve lobectomy. This technique might be also useful for other types of extended sleeve lobectomy and lung transplantation to adjust caliber changes of bronchi.
- 17 March 2004
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 7 (3) , 250-257
HBL-3 Cell Line, Derived from Precursor B-cell Lymphoblastic Leukemia, Lacks Somatic Hypermutation of Immunoglobulin Heavy Chain Variable Region Genes
Somatic mutation (SM) analysis provides a useful tool for understanding the stages at which neoplastic differentiate from normal B-cells. B-cell precursor neoplasms are considered to be somatically premutational. However, the variable frequency of SM of the variable region (VH) genes has been described in cases of precursor B-cell acute lymphoblastic leukemia (PB-ALL). To better characterize PB-ALL based on the differentiation stage, we investigated the SM of the VH genes expressed by tumor cells of the surface immunoglobulin (sIg)- HBL-3 cell line derived from childhood PB-ALL. In the HBL-3 cell line, the rearranged Ig heavy chain VH gene sequence showed no SM in the complementarity-determining regions of 1, 2, and 3, or in the framework regions of 1, 2, and 3 relative to the putative germline VH gene sequences. In addition, the VH segment of HBL-3 cells showed no intraclonal sequence heterogeneity, indicating ongoing SM. Our data demonstrated that HBL-3 cells express unmutated and developmentally regulated rearrangement of VH genes at the stage of B-cell precursor cells. HBL-3 cells, which are derived only from the sIg- PB-ALL, showed that SM cannot be recognized in VH genes of tumor cells before the expression of sIg.
- 17 March 2004
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 7 (3) , 250-257
HBL-3 Cell Line, Derived from Precursor B-cell Lymphoblastic Leukemia, Lacks Somatic Hypermutation of Immunoglobulin Heavy Chain Variable Region Genes
Somatic mutation (SM) analysis provides a useful tool for understanding the stages at which neoplastic differentiate from normal B-cells. B-cell precursor neoplasms are considered to be somatically premutational. However, the variable frequency of SM of the variable region (VH) genes has been described in cases of precursor B-cell acute lymphoblastic leukemia (PB-ALL). To better characterize PB-ALL based on the differentiation stage, we investigated the SM of the VH genes expressed by tumor cells of the surface immunoglobulin (sIg)- HBL-3 cell line derived from childhood PB-ALL. In the HBL-3 cell line, the rearranged Ig heavy chain VH gene sequence showed no SM in the complementarity-determining regions of 1, 2, and 3, or in the framework regions of 1, 2, and 3 relative to the putative germline VH gene sequences. In addition, the VH segment of HBL-3 cells showed no intraclonal sequence heterogeneity, indicating ongoing SM. Our data demonstrated that HBL-3 cells express unmutated and developmentally regulated rearrangement of VH genes at the stage of B-cell precursor cells. HBL-3 cells, which are derived only from the sIg- PB-ALL, showed that SM cannot be recognized in VH genes of tumor cells before the expression of sIg.
- 22 September 2002
- Published by Wiley in Pathology International
- Vol. 52 (9) , 586-594
Analysis of immunoglobulin VH genes in CD10‐positive diffuse large B‐cell lymphoma
CD10, a proteolytic enzyme seen in germinal center cells and in the majority of follicular lymphomas, is occasionally expressed in diffuse large B‐cell lymphomas (DLBCL). To clarify the origin and cellular characteristics of CD10‐positive DLBCL, we analyzed 36 de novo cases of DLBCL for somatic mutations of the immunoglobulin heavy chain variable region (VH) genes and for their immunophenotypes. Expression greater than that of grade 2 Bcl‐6 was observed in 11 of the 30 CD10‐negative cases (37%) and in all six CD10‐positive cases (100%; P < 0.05) without expression of CD5, CD23, cyclin D1, CD30 or CD138. The average mutation frequencies of the six CD10‐positive and 30 CD10‐negative DLBCL were 12.9 and 9.8%, respectively. The range of SM frequencies in CD10‐positive DLBCL (9.52–18.06) was distinctly narrower than that observed for CD10‐negative DLBCL (0.69–26.89). These findings seem to indicate that CD10‐positive DLBCL, originating from germinal center B cells, is a genetically and immunophenotypically more homogeneous group than CD10‐negative DLBCL. Furthermore, three extranodal lymphomas, in five of the six CD10‐positive DLBCL, showed ongoing mutation, indicating that antigen‐driven, high‐affinity somatic mutation may play an important role in clonal expansion in CD10‐positive DLBCL. All four extranodal cases of the six CD10‐positive DLBCL showed ongoing mutation and/or bcl‐2/JH rearrangement. This result suggests that the cell origin of extranodal CD10‐positive DLBCL may be the same as that of follicular lymphomas.
- 22 September 2002
- Published by Wiley in Pathology International
- Vol. 52 (9) , 586-594
Analysis of immunoglobulin VH genes in CD10‐positive diffuse large B‐cell lymphoma
CD10, a proteolytic enzyme seen in germinal center cells and in the majority of follicular lymphomas, is occasionally expressed in diffuse large B‐cell lymphomas (DLBCL). To clarify the origin and cellular characteristics of CD10‐positive DLBCL, we analyzed 36 de novo cases of DLBCL for somatic mutations of the immunoglobulin heavy chain variable region (VH) genes and for their immunophenotypes. Expression greater than that of grade 2 Bcl‐6 was observed in 11 of the 30 CD10‐negative cases (37%) and in all six CD10‐positive cases (100%; P < 0.05) without expression of CD5, CD23, cyclin D1, CD30 or CD138. The average mutation frequencies of the six CD10‐positive and 30 CD10‐negative DLBCL were 12.9 and 9.8%, respectively. The range of SM frequencies in CD10‐positive DLBCL (9.52–18.06) was distinctly narrower than that observed for CD10‐negative DLBCL (0.69–26.89). These findings seem to indicate that CD10‐positive DLBCL, originating from germinal center B cells, is a genetically and immunophenotypically more homogeneous group than CD10‐negative DLBCL. Furthermore, three extranodal lymphomas, in five of the six CD10‐positive DLBCL, showed ongoing mutation, indicating that antigen‐driven, high‐affinity somatic mutation may play an important role in clonal expansion in CD10‐positive DLBCL. All four extranodal cases of the six CD10‐positive DLBCL showed ongoing mutation and/or bcl‐2/JH rearrangement. This result suggests that the cell origin of extranodal CD10‐positive DLBCL may be the same as that of follicular lymphomas.
- 1 July 2001
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 25 (7) , 964-969
Rhabdoid Papillary Meningioma
We have studied an uncommon case of rhabdoid papillary meningioma in a 15-year-old boy with a dura-based mass arising in the left posterior fossa. The patient exhibited prominent extracranial extension during the past 6 years, consisting of a mixture of both perivascular pseudopapillary growth and rhabdoid cytologic features of neoplastic meningothelial cells. The meningothelial features were evidenced by the focal whorl formation of tumor cells, coexpression of epithelial membrane antigen and vimentin, and ultrastructural findings of interdigitated cytoplasmic process and intercellular junction. However, the regional and histologic resemblances to ependymoma were further complicated by unexpected focal expression of glial fibrillary acidic protein, neurofilament, and α-smooth muscle actin of the tumor cells. The rhabdoid morphology was characterized by sheets of tumor cells with eccentric nuclei and abundant eosinophilic cytoplasm with often recognizable intracytoplasmic hyaline inclusions. These inclusions revealed ultrastructural paranuclear whorls of intermediate filaments, ruling out the other forms of intracytoplasmic eosinophilic inclusions resembling rhabdoid morphology. Diagnosis of an unusual rhabdoid papillary meningioma with aggressive behavior is resoluble by immunohistochemical and ultrastructural analyses.
- 1 July 2001
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 25 (7) , 964-969
Rhabdoid Papillary Meningioma
We have studied an uncommon case of rhabdoid papillary meningioma in a 15-year-old boy with a dura-based mass arising in the left posterior fossa. The patient exhibited prominent extracranial extension during the past 6 years, consisting of a mixture of both perivascular pseudopapillary growth and rhabdoid cytologic features of neoplastic meningothelial cells. The meningothelial features were evidenced by the focal whorl formation of tumor cells, coexpression of epithelial membrane antigen and vimentin, and ultrastructural findings of interdigitated cytoplasmic process and intercellular junction. However, the regional and histologic resemblances to ependymoma were further complicated by unexpected focal expression of glial fibrillary acidic protein, neurofilament, and α-smooth muscle actin of the tumor cells. The rhabdoid morphology was characterized by sheets of tumor cells with eccentric nuclei and abundant eosinophilic cytoplasm with often recognizable intracytoplasmic hyaline inclusions. These inclusions revealed ultrastructural paranuclear whorls of intermediate filaments, ruling out the other forms of intracytoplasmic eosinophilic inclusions resembling rhabdoid morphology. Diagnosis of an unusual rhabdoid papillary meningioma with aggressive behavior is resoluble by immunohistochemical and ultrastructural analyses.